JPMORGAN CHASE & CO - J P MORGAN EXCHANGE-TRADED F ownership

J P MORGAN EXCHANGE-TRADED F's ticker is JVAL and the CUSIP is 46641Q753. A total of 2 filers reported holding J P MORGAN EXCHANGE-TRADED F in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of J P MORGAN EXCHANGE-TRADED F
ValueSharesWeighting
Q3 2023$2,236,445
+2.8%
64,562
+5.9%
0.00%
Q2 2023$2,176,095
+47.3%
60,989
+40.6%
0.00%
Q1 2023$1,477,297
+157059.3%
43,374
+53.0%
0.00%
Q4 2022$940
-100.0%
28,357
-97.9%
0.00%
-100.0%
Q2 2022$43,136,000
-72.5%
1,343,396
-69.6%
0.01%
-68.4%
Q3 2021$157,035,000
-79.9%
4,421,026
-79.5%
0.02%
-79.6%
Q2 2021$781,722,000
+72.3%
21,588,579
+63.4%
0.09%
+52.5%
Q1 2021$453,666,000
+2537.4%
13,211,010
+1820.2%
0.06%
+1933.3%
Q3 2020$17,201,000
-1.0%
688,000
-4.8%
0.00%0.0%
Q2 2020$17,379,000
+13.9%
723,000
-4.0%
0.00%
-25.0%
Q1 2020$15,252,000
-39.7%
753,000
-13.7%
0.00%
-20.0%
Q4 2019$25,308,000
-5.4%
873,000
-12.8%
0.01%0.0%
Q3 2019$26,763,000
+1.5%
1,001,0010.0%0.01%0.0%
Q2 2019$26,360,000
+1.5%
1,001,0010.0%0.01%0.0%
Q1 2019$25,968,000
+12.1%
1,001,001
+0.3%
0.01%0.0%
Q4 2018$23,164,000
-13.6%
998,0000.0%0.01%0.0%
Q3 2018$26,810,000
+5.3%
998,0000.0%0.01%0.0%
Q2 2018$25,472,000
-1.9%
998,0000.0%0.01%
-16.7%
Q1 2018$25,958,000
-0.3%
998,0000.0%0.01%
+20.0%
Q4 2017$26,048,000998,0000.01%
Other shareholders
J P MORGAN EXCHANGE-TRADED F shareholders Q4 2017
NameSharesValueWeighting ↓
AVALON CAPITAL MANAGEMENT 317,790$10,204,0004.18%
Integrity Advisory, LLC 93,847$3,013,0002.95%
COBBLESTONE CAPITAL ADVISORS LLC /NY/ 1,006,445$32,317,0002.48%
Jaffetilchin Investment Partners, LLC 503,446$16,166,0001.91%
RWA WEALTH PARTNERS, LLC 686,794$22,053,0001.49%
Brinker Capital Investments, LLC 1,713,043$55,006,0001.04%
Capital Analysts, LLC 447,861$14,381,0001.00%
TCG Advisory Services, LLC 84,178$2,703,0000.84%
Sigma Planning Corp 436,004$14,000,0000.49%
Strategic Asset Management, LLC 7,998$257,0000.41%
View complete list of J P MORGAN EXCHANGE-TRADED F shareholders